← All cohort news

Allotrope Medical Announces FDA Clearance of StimSite™

DateNovember 17, 2020
CategoriesCohort News
Allotrope Medical logo

Allotrope Medical™ Inc., a company committed to advancing surgical safety and precision, today announced its FDA clearance of their device, StimSite. StimSite provides ob/gyns, general and colorectal surgeons the new ability to use their existing surgical instruments to help locate and identify ureters using electrical stimulation. Ureter identification is a critical step in safely advancing in operations such as hysterectomies and colon.

“Whether it is a gynecologic or colorectal operation, a significant portion of OR time is spent looking for the Ureter and keeping it safe. StimSite provides surgeons with an elegant tool to help rapidly identify the ureter, keep it safe from harm, and promote the progression of a pelvic operation. It should be in the toolbox of every surgeon doing pelvic surgery,” commented Brian Dunkin MD, past president of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).

Alan Greenberg MD in Frisco, Texas was the first physician to use StimSite during both laparoscopic and robotic gynecologic procedures. He noted, “StimSite is extremely helpful when trying to find the Ureter, and enables the surgeon to save valuable operating time while making the surgery more efficient and safe.”

Read More

Share Link :